Grifols (GRFS) Prepaid Assets (2009 - 2025)
Grifols' (GRFS) quarterly Prepaid Assets came in at $75.7 million in Q4 2025, down 1.66% YoY from $76.9 million in Q4 2024, and down 1.66% on a QoQ basis from $76.9 million in Q4 2024.
Grifols (GRFS) Prepaid Assets (2009 - 2025) Analysis & Trends
Grifols (GRFS) has 17 years of Prepaid Assets data on file, last reported at $75.7 million in Q4 2025.
- Quarterly Prepaid Assets fell 1.66% year-over-year to $75.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $75.7 million (down 1.66% YoY) and the FY2025 annual result came in at $75.7 million, down 1.66% from the prior year.
- Prepaid Assets retreated to $75.7 million in Q4 2025, from $76.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $84.4 million in Q4 2022 to a low of $73.3 million in Q4 2021.
- A 5-year average of $78.0 million and a median of $76.9 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets climbed 18.81% — and 2023, when it retreated 5.68%.
- Tracing GRFS's Prepaid Assets over 5 years: stood at $73.3 million in 2021, then increased by 15.07% to $84.4 million in 2022, then slipped by 5.68% to $79.6 million in 2023, then retreated by 3.29% to $76.9 million in 2024, then retreated by 1.66% to $75.7 million in 2025.
- The last three Prepaid Assets figures came in at $75.7 million (Q4 2025), $76.9 million (Q4 2024), and $79.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.66 Mn |
| Dec 31, 2024 | 76.94 Mn |
| Dec 31, 2023 | 79.56 Mn |
| Dec 31, 2022 | 84.35 Mn |
| Dec 31, 2021 | 73.30 Mn |
| Dec 31, 2020 | 61.70 Mn |
| Sep 30, 2020 | 51.12 Mn |
| Mar 31, 2020 | 50.70 Mn |
| Dec 31, 2019 | 64.32 Mn |
| Sep 30, 2019 | 81.73 Mn |
| Mar 31, 2019 | 24.58 Mn |
| Dec 31, 2018 | 48.33 Mn |
| Sep 30, 2018 | 74.37 Mn |
| Jun 30, 2018 | 42.14 Mn |
| Mar 31, 2018 | 37.36 Mn |
| Dec 31, 2017 | 38.09 Mn |
| Jun 30, 2017 | 28.72 Mn |
| Dec 31, 2016 | 52.18 Mn |
| Sep 30, 2016 | 34.73 Mn |
| Jun 30, 2016 | 29.34 Mn |